Pale Fire Capital SE - Q3 2023 holdings

$995 Million is the total value of Pale Fire Capital SE's 74 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 580.0% .

 Value Shares↓ Weighting
STNG BuySCORPIO TANKERS INC$42,208,837
+21.5%
779,912
+6.0%
4.24%
+68.0%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$6,071,80070,000
+100.0%
0.61%
DAR BuyDARLING INGREDIENTS INC$4,630,140
+81.5%
88,700
+121.8%
0.46%
+151.4%
TRIP BuyTRIPADVISOR INC$2,647,179
+435.1%
159,661
+432.2%
0.27%
+638.9%
VIRT NewVIRTU FINL INCcl a$1,721,28499,669
+100.0%
0.17%
CUZ NewCOUSINS PPTYS INC$1,557,42976,457
+100.0%
0.16%
DHC BuyDIVERSIFIED HEALTHCARE TR$681,151
+111.4%
351,109
+145.2%
0.07%
+195.7%
NOMD NewNOMAD FOODS LTD$376,90824,764
+100.0%
0.04%
FLWS New1 800 FLOWERS COM INCcl a$351,85550,265
+100.0%
0.04%
RPHM NewRENEO PHARMACEUTICALS INC$113,09014,851
+100.0%
0.01%
IGMS NewIGM BIOSCIENCES INC$105,21812,601
+100.0%
0.01%
CELC NewCELCUITY INC$95,13810,409
+100.0%
0.01%
KNTE BuyKINNATE BIOPHARMA INC$98,244
+36.9%
70,174
+196.3%
0.01%
+100.0%
PRLD NewPRELUDE THERAPEUTICS INC$95,11330,781
+100.0%
0.01%
CMRX NewCHIMERIX INC$94,92098,896
+100.0%
0.01%
ALDX NewALDEYRA THERAPEUTICS INC$98,19614,700
+100.0%
0.01%
EWTX NewEDGEWISE THERAPEUTICS INC$89,64615,645
+100.0%
0.01%
LIFE NewATYR PHARMA INC$88,25455,857
+100.0%
0.01%
ACRS NewACLARIS THERAPEUTICS INC$89,05013,000
+100.0%
0.01%
MNKD NewMANNKIND CORPcall$94,16422,800
+100.0%
0.01%
KURA NewKURA ONCOLOGY INC$91,65610,050
+100.0%
0.01%
CMPX NewCOMPASS THERAPEUTICS INC$88,95545,155
+100.0%
0.01%
KZR NewKEZAR LIFE SCIENCES INC$81,93368,851
+100.0%
0.01%
NewERASCA INC$82,93942,101
+100.0%
0.01%
TERN NewTERNS PHARMACEUTICALS INC$76,46615,202
+100.0%
0.01%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$68,70515,100
+100.0%
0.01%
NewTENAYA THERAPEUTICS INC$71,65528,100
+100.0%
0.01%
NSTG NewNANOSTRING TECHNOLOGIES INC$62,26436,200
+100.0%
0.01%
LRMR NewLARIMAR THERAPEUTICS INC$47,55812,040
+100.0%
0.01%
CDTX NewCIDARA THERAPEUTICS INC$51,21454,356
+100.0%
0.01%
NewRENEW ENERGY GLOBAL PLC$54,30010,000
+100.0%
0.01%
NGM NewNGM BIOPHARMACEUTICALS INC$36,16633,800
+100.0%
0.00%
NewTSCAN THERAPEUTICS INC$42,43216,575
+100.0%
0.00%
GRTX NewGALERA THERAPEUTICS INC$3,04717,400
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DOLE PLC4Q3 202350.4%
GROUPON INC4Q3 202336.3%
NAVIOS MARITIME PARTNERS L P4Q3 20236.4%
ARLO TECHNOLOGIES INC4Q3 20238.0%
KINROSS GOLD CORP4Q3 20231.6%
GLOBAL SHIP LEASE INC NEW4Q3 20231.1%
CENTERRA GOLD INC4Q3 20231.1%
INTERNATIONAL SEAWAYS INC3Q3 20237.9%
TALOS ENERGY INC3Q3 20234.8%
BURFORD CAP LTD3Q2 20233.4%

View Pale Fire Capital SE's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
42024-01-23
42023-11-20
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-08
42022-12-22
3/A2022-12-20
42022-09-01

View Pale Fire Capital SE's complete filings history.

Export Pale Fire Capital SE's holdings